Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.19 +0.15 (+0.60%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal ↗

September 22, 2025

The deal follows two high-profile failures for Pfizer, which is trying to broaden its small pipeline in weight loss.

Via Investor's Business Daily

Pfizer Tries To Revitalize Obesity Portfolio With $5 Billion Matsera Deal ↗

September 22, 2025

Pfizer will buy Metsera for $4.9 billion plus milestone payments, adding incretin, amylin, and oral obesity drug candidates to its pipeline.

Via Benzinga

3 Dirt-Cheap Stocks to Buy Right Now ↗

September 22, 2025

These stocks share several common denominators, including attractive valuations.

Via The Motley Fool

Topics Intellectual Property

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market ↗

September 22, 2025

Pfizer Inc. (NYSE: PFE) stock climbed 1.87% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ: MTSR), a developer of anti-obesity drugs.

Via Benzinga

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up ↗

September 22, 2025

Via Stocktwits

P/E Ratio Insights for Pfizer ↗

September 18, 2025

Via Benzinga

Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details ↗

September 22, 2025

The upfront purchase price of $47.50 per share implies a premium of 43% from Metsera’s closing share price on Friday.

Via Stocktwits

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio

September 22, 2025

From Pfizer Inc.

Via Business Wire

Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report ↗

September 22, 2025

Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with President's priority.

Via Benzinga

Topics Government

3 Bargain Stocks for Investors on a Budget ↗

September 21, 2025

If every one of your dollars counts, make sure you're getting the biggest possible bang for your buck.

Via The Motley Fool

Topics Economy

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon ↗

September 20, 2025

There is a "for sale" sign on the sector, and these two stocks look particularly attractive at their current levels.

Via The Motley Fool

Topics Government Intellectual Property World Trade

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill ↗

September 20, 2025

A high yield is only one part of the story when it comes to picking dividend stocks.

Via The Motley Fool

Topics Intellectual Property

Prediction: These Could Be the Best-Performing Value Stocks Through 2030 ↗

September 20, 2025

These stocks are bargains now. But they probably won't be by the end of this decade.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids ↗

September 19, 2025

Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.

Via Investor's Business Daily

Stay informed about the most active stocks in the S&P500 index on Friday's session. ↗

September 19, 2025

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Via Chartmill

Eli Lilly Poised for Blockbuster Q3 2025 with Skyrocketing EPS and Revenue Projections

September 19, 2025

Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is gearing up for a stellar third quarter of 2025, with analysts projecting massive earnings per share (EPS) and revenue growth. The optimistic...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

GLP-1 Titans Clash: Eli Lilly Challenges Novo Nordisk's Dominance in a Spiraling Market Battle

September 19, 2025

The pharmaceutical industry is witnessing an unprecedented showdown as Eli Lilly (NYSE: LLY) rapidly encroaches upon Novo Nordisk's (NYSE: NVO) long-held lead in the burgeoning GLP-1 (glucagon-like...

Via MarketMinute

Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape

September 19, 2025

Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery...

Via MarketMinute

Topics Animal Testing Artificial Intelligence Intellectual Property

3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

September 19, 2025

Everything is going great for the stock market right now. But a plot twist could be on the way.

Via The Motley Fool

Topics Economy

Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months ↗

September 19, 2025

Viking's stock took a beating last month, and it has opened up a glorious buying opportunity for investors.

Via The Motley Fool

Topics Bankruptcy

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗

September 18, 2025

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps,...

Via Benzinga

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut ↗

September 18, 2025

The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters.

Via Investor's Business Daily

Topics Government

Federal Reserve Navigates Stagflationary Headwinds with Dovish Pivot

September 18, 2025

Washington D.C. - The U.S. Federal Reserve finds itself at a critical juncture, facing an economic environment that is increasingly raising the specter of "stagflation" – a challenging combination of...

Via MarketMinute

Topics Economy Supply Chain World Trade

1 Large-Cap Stock Worth Your Attention and 2 We Find Risky

September 18, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

The Specter of Stagflation: Is the Economy Headed for Stagnant Growth and High Inflation?

September 17, 2025

The U.S. Federal Reserve’s recent decision to cut interest rates has sent a tremor of concern through financial markets, sparking fears of a potential return to stagflation—an economic phenomenon...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

September 17, 2025

From Arvinas Inc.

Via GlobeNewswire

Most active S&P500 stocks in Wednesday's session ↗

September 17, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace...

Via Chartmill

5 Best High-Yield Dividend Stocks to Buy Now ↗

September 17, 2025

These five dividend stocks yield between 3.5% and 7.1%, but more importantly, they have the cash flows and business models to keep paying through the next downturn.

Via The Motley Fool

3 Value Stocks We Find Risky

September 17, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Pfizer (NY:PFE)

All News about Pfizer

Starting at $3.75/week.

Subscribe Today